Education
About Us
Working with TipRanks
Follow Us
Decheng Capital Global Life Sciences Fund IV, L.P. Insider Profile
4 Followers
Decheng Capital Global Life Sciences Fund IV, L.P., Ten Percent Owner at CG Oncology, Inc., holds 3.92M shares in Aardvark Therapeutics, Inc. (Ticker: AARD), holds 4.96M shares in CG Oncology, Inc. (Ticker: CGON).
Decheng Capital Global Life Sciences Fund IV, L.P. CG Oncology, Inc. (CGON)Ten Percent Owner
CG Oncology, Inc. (CGON)
Ten Percent Owner
Not Ranked
Decheng Capital Global Life Sciences Fund IV, L.P. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Decheng Capital Global Life Sciences Fund IV, L.P. holds in companies
Most Profitable Insider Trade
The most profitable trade made by Decheng Capital Global Life Sciences Fund IV, L.P.
Decheng Capital Global Life Sciences Fund IV, L.P.'s Trading History
CG Oncology, Inc.
Jan 31, 2024
Ten Percent Owner
Uninformative Buy
―
$136.47M
Aardvark Therapeutics, Inc.
Feb 19, 2025
Ten Percent Owner
Uninformative Buy
―
$58.37M
List of latest transactions for each holding click on a transaction to see Decheng Capital Global Life Sciences Fund IV, L.P.'s performance on stock
You May Also Like
Decheng Capital Global Life Sciences Fund IV, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Decheng Capital Global Life Sciences Fund IV, L.P.?
The percentage of profitable transactions made by Decheng Capital Global Life Sciences Fund IV, L.P. is ―.
What is the average return per transaction made by Decheng Capital Global Life Sciences Fund IV, L.P.?
The average return per transaction made by Decheng Capital Global Life Sciences Fund IV, L.P. is ―.
What stocks does Decheng Capital Global Life Sciences Fund IV, L.P. hold?
Decheng Capital Global Life Sciences Fund IV, L.P. holds: CGON, AARD stocks.
What was Decheng Capital Global Life Sciences Fund IV, L.P.’s latest transaction?
Decheng Capital Global Life Sciences Fund IV, L.P. latest transaction was an Uninformative Buy of ―.
What was Decheng Capital Global Life Sciences Fund IV, L.P.'s most profitable transaction?
Decheng Capital Global Life Sciences Fund IV, L.P.’s most profitable transaction was an Informative Buy of CGON stock on January 31, 2024. The return on the trade was -19.20%.
What is Decheng Capital Global Life Sciences Fund IV, L.P.'s role in CG Oncology, Inc.?
Decheng Capital Global Life Sciences Fund IV, L.P.'s role in CG Oncology, Inc. is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.